180 related articles for article (PubMed ID: 18436240)
21. Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective Studies.
Peters XQ; Malinga TH; Agoni C; Olotu FA; Soliman MES
Anticancer Agents Med Chem; 2019; 19(16):1920-1934. PubMed ID: 31648650
[TBL] [Abstract][Full Text] [Related]
22. Solution NMR assignment of the ARC4 domain of human tankyrase 2.
Zaleska M; Pollock K; Collins I; Guettler S; Pfuhl M
Biomol NMR Assign; 2019 Apr; 13(1):255-260. PubMed ID: 30847846
[TBL] [Abstract][Full Text] [Related]
23. Structural basis of tankyrase activation by polymerization.
Pillay N; Mariotti L; Zaleska M; Inian O; Jessop M; Hibbs S; Desfosses A; Hopkins PCR; Templeton CM; Beuron F; Morris EP; Guettler S
Nature; 2022 Dec; 612(7938):162-169. PubMed ID: 36418402
[TBL] [Abstract][Full Text] [Related]
24. Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency.
Zimmerlin L; Zambidis ET
Exp Cell Res; 2020 May; 390(1):111935. PubMed ID: 32151493
[TBL] [Abstract][Full Text] [Related]
25. Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors.
Haikarainen T; Narwal M; Joensuu P; Lehtiö L
ACS Med Chem Lett; 2014 Jan; 5(1):18-22. PubMed ID: 24900770
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into SAM domain-mediated tankyrase oligomerization.
DaRosa PA; Ovchinnikov S; Xu W; Klevit RE
Protein Sci; 2016 Sep; 25(9):1744-52. PubMed ID: 27328430
[TBL] [Abstract][Full Text] [Related]
27. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.
Riffell JL; Lord CJ; Ashworth A
Nat Rev Drug Discov; 2012 Dec; 11(12):923-36. PubMed ID: 23197039
[TBL] [Abstract][Full Text] [Related]
28. Regulation of tankyrase activity by a catalytic domain dimer interface.
Fan C; Yarravarapu N; Chen H; Kulak O; Dasari P; Herbert J; Yamaguchi K; Lum L; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1780-1785. PubMed ID: 30055800
[TBL] [Abstract][Full Text] [Related]
29. NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis.
Chang W; Dynek JN; Smith S
Biochem J; 2005 Oct; 391(Pt 2):177-84. PubMed ID: 16076287
[TBL] [Abstract][Full Text] [Related]
30. Cross-species difference in telomeric function of tankyrase 1.
Muramatsu Y; Ohishi T; Sakamoto M; Tsuruo T; Seimiya H
Cancer Sci; 2007 Jun; 98(6):850-7. PubMed ID: 17433040
[TBL] [Abstract][Full Text] [Related]
31. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors.
Wahlberg E; Karlberg T; Kouznetsova E; Markova N; Macchiarulo A; Thorsell AG; Pol E; Frostell Å; Ekblad T; Öncü D; Kull B; Robertson GM; Pellicciari R; Schüler H; Weigelt J
Nat Biotechnol; 2012 Feb; 30(3):283-8. PubMed ID: 22343925
[TBL] [Abstract][Full Text] [Related]
32. Insights of tankyrases: A novel target for drug discovery.
Damale MG; Pathan SK; Shinde DB; Patil RH; Arote RB; Sangshetti JN
Eur J Med Chem; 2020 Dec; 207():112712. PubMed ID: 32877803
[TBL] [Abstract][Full Text] [Related]
33. Structural basis and selectivity of tankyrase inhibition by a Wnt signaling inhibitor WIKI4.
Haikarainen T; Venkannagari H; Narwal M; Obaji E; Lee HW; Nkizinkiko Y; Lehtiö L
PLoS One; 2013; 8(6):e65404. PubMed ID: 23762361
[TBL] [Abstract][Full Text] [Related]
34. Novel insight into the function of tankyrase.
Kim MK
Oncol Lett; 2018 Dec; 16(6):6895-6902. PubMed ID: 30546421
[TBL] [Abstract][Full Text] [Related]
35. Tankyrases: structure, function and therapeutic implications in cancer.
Haikarainen T; Krauss S; Lehtio L
Curr Pharm Des; 2014; 20(41):6472-88. PubMed ID: 24975604
[TBL] [Abstract][Full Text] [Related]
36. Screening and structural analysis of flavones inhibiting tankyrases.
Narwal M; Haikarainen T; Fallarero A; Vuorela PM; Lehtiö L
J Med Chem; 2013 May; 56(9):3507-17. PubMed ID: 23574272
[TBL] [Abstract][Full Text] [Related]
37. GDP-mannose-4,6-dehydratase is a cytosolic partner of tankyrase 1 that inhibits its poly(ADP-ribose) polymerase activity.
Bisht KK; Dudognon C; Chang WG; Sokol ES; Ramirez A; Smith S
Mol Cell Biol; 2012 Aug; 32(15):3044-53. PubMed ID: 22645305
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases.
Kumpan K; Nathubhai A; Zhang C; Wood PJ; Lloyd MD; Thompson AS; Haikarainen T; Lehtiö L; Threadgill MD
Bioorg Med Chem; 2015 Jul; 23(13):3013-32. PubMed ID: 26026769
[TBL] [Abstract][Full Text] [Related]
39. TBM Hunter: Identify and Score Canonical, Extended, and Unconventional Tankyrase-Binding Motifs in Any Protein.
Clements CM; Shellman SX; Shellman MH; Shellman YG
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069287
[TBL] [Abstract][Full Text] [Related]
40. Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation.
Muramatsu Y; Tahara H; Ono T; Tsuruo T; Seimiya H
Exp Cell Res; 2008 Mar; 314(5):1115-24. PubMed ID: 18221737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
